Skip to main content
All lobbying clients

FRESENIUS KABI

Lobbying client · District of Columbia · filed 2025 to 2026

Healthcare/pharmaceutical company

$420,000 Reported spend
14 Filings counted
2 Outside firms hired
3 Bills named

Spend is reported income plus in-house expenses across 14 filings. The LDA keeps a separate client record for every registrant that files for a client, so this page adds up 2 records, one per registrant listed below. Records are combined when the client name matches once case, punctuation and endings such as Inc. or LLC are set aside; for a city, county or port the state has to match as well.

 Who filed for this client 2

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

 Bills named in these filings 3
  • H.R. 3269
    ETHIC Act
    5 filings
  • S. 2276
    ETHIC Act
    5 filings
  • S. 2658
    Medication Affordability and Patent Integrity Act
    5 filings
 Reported by year 2 years
  • 2026 $225,000 6 filings
  • 2025 $195,000 8 filings
 Issues lobbied 4

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 5
  • HOUSE OF REPRESENTATIVES 11
  • SENATE 11
  • Commerce, Dept of (DOC) 4
  • Health & Human Services, Dept of (HHS) 4
  • White House Office 4
 Recent filings 14 total
Q3 report
S-3 GROUP
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $30,000 income · posted Oct 16, 2026
View →
Q2 report
S-3 GROUP
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $30,000 income · posted Jul 17, 2026
View →
Q3 terminationNo activity
EAST END GROUP, LLC
3rd Quarter 2026 (July 1 - Sep 30) · $45,000 income · posted Jul 15, 2026
View →
Q2 report
EAST END GROUP, LLC
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $45,000 income · posted Jul 15, 2026
View →
Q1 report
S-3 GROUP
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $30,000 income · posted Apr 17, 2026
View →
Q1 report
EAST END GROUP, LLC
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $45,000 income · posted Apr 14, 2026
View →
Q4 report
EAST END GROUP, LLC
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $45,000 income · posted Jan 20, 2026
View →
Q4 report
S-3 GROUP
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $30,000 income · posted Jan 15, 2026
View →
Q3 report
S-3 GROUP
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $30,000 income · posted Oct 20, 2025
View →
Q3 report
EAST END GROUP, LLC
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $30,000 income · posted Oct 20, 2025
View →
Registration
EAST END GROUP, LLC
3rd Quarter 2025 (July 1 - Sep 30) · posted Oct 17, 2025
View →
Q2 report
S-3 GROUP
2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $30,000 income · posted Jul 18, 2025
View →
Q1 report
S-3 GROUP
1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · $30,000 income · posted Apr 21, 2025
View →
Registration
S-3 GROUP
1st Quarter 2025 (Jan 1 - Mar 31) · posted Feb 7, 2025
View →
 Foreign entities disclosed 1
  • FRESENIUS KABI SWISSBIOSIM GMBH Switzerland named on 1 filing · highest disclosed ownership 100% · largest disclosed contribution $0

Section 7 of the LD-2: a foreign company or government that owns part of the client, pays toward the lobbying, or benefits from it. Figures are the highest single disclosure across these filings, not a sum: the same stake is re-disclosed each quarter.

Filings through , the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem